Nuzenio

Allogene Therapeutics

Allogene Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 17 latest news signals 11 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 02:12:07 GMTAllogene Therapeutics (ALLO) stake: Belldegrun group reports 3.9% ownership - Stock Titan
Fri, 07 Aug 2026 12:33:35 GMTState Street Corporation (ALLO) discloses 5.5% beneficial stake in Allogene - Stock Titan
Thu, 06 Aug 2026 11:18:12 GMTAnalysts Offer Insights on Healthcare Companies: Pfizer (PFE), Ultragenyx Pharmaceutical (RARE) and Allogene Therapeutics (ALLO) - theglobeandmail.com
Wed, 05 Aug 2026 13:08:26 GMTAllogene Therapeutics (ALLO) Expected to Release Quarterly Earnings on Wednesday - MarketBeat
Wed, 05 Aug 2026 11:31:00 GMTWilliam Blair Maintains Allogene Therapeutics(ALLO.US) With Buy Rating - Moomoo
Tue, 04 Aug 2026 18:26:30 GMTAllogene Therapeutics Q2 Results: Earnings Call Set for Aug 12 - scanx.trade

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Allogene Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.